A detailed history of Quarry LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Quarry LP holds 10,000 shares of AUPH stock, worth $77,700. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,000
Previous 12,000 16.67%
Holding current value
$77,700
Previous $108 Million 25.39%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$7.55 - $8.77 $15,100 - $17,540
-2,000 Reduced 16.67%
10,000 $80.4 Million
Q4 2024

Feb 14, 2025

BUY
$6.75 - $10.44 $81,000 - $125,280
12,000 New
12,000 $108 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.1B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.